![]()
MIRA INFORM
REPORT
|
Report Date : |
07.04.2011 |
IDENTIFICATION DETAILS
|
Name : |
ORGANO PHARMACEUTICAL & CHEMICAL
INDUSTRIES CO |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment : |
2006 |
|
|
|
|
Legal Form : |
Limited Liability Partnership |
|
|
|
|
Line of Business : |
Manufacturer of pharmaceutical products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 600,000 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
Usually Correct |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : ORGANO PHARMACEUTICAL & CHEMICAL INDUSTRIES CO
Country of Origin :
Legal Form : Limited Liability Partnership
Registration Date : 2006
Issued Capital : £E 500,000
Paid up Capital : £E 500,000
Total Workforce : 100
Activities : Manufacture of pharmaceutical products
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
Recommended Credit Limit : US$ 600,000
Person Interviewed : Dr Moafik Ali Abdullah Sakr, Managing Partner
ORGANO PHARMACEUTICAL & CHEMICAL INDUSTRIES
CO
Location :
Street :
Town :
Country :
Telephone : (20-2) 44665135
Facsimile : (20-2) 44665135
Email : organomix@hotmail.com
Subject operates
from a medium sized suite of offices and a factory that are rented and located
in the Industrial Area of Cairo.
Branch Office (s)
Location Description
·
Tel: (20-2) 33878893
Fax: (20-2) 37401321
Name Position
·
Dr
Moafik Ali Abdullah Sakr Managing
Partner
·
Dr Asma
Moafik Ali Abdullah Sakr Partner
·
Dr
Yaser Mohamed Ali Commercial
Manager
Date of Establishment : 2006
Legal Form :
Limited Liability
Partnership
Issued Capital : £E 500,000
Paid up Capital : £E 500,000
·
Dr
Moafik Ali Abdullah Sakr
·
Dr Asma
Moafik Ali Abdullah Sakr
Activities: Engaged in the manufacture of
pharmaceutical products, with approximately 50 registered brands.
Import
Countries:
Subject has a
workforce of 100 employees.
Companies
registered in
·
Faisal
Islamic Bank
Dokki,
Tel: (20-2) 22753165
No complaints
regarding subject’s payments have been reported.
According to local
sources subject is making steady progress in the local business market and
nothing detrimental has been reported regarding the manner in which payments
are fulfilled. As such the business is considered to be a fair trade risk and
the above credit figure is deemed admissible.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.22 |
|
|
1 |
Rs.72.25 |
|
Euro |
1 |
Rs.63.09 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.